Use of daclizumab decreases the frequency of early allograft rejection in de-novo heart transplant recipients: Ainat Beniaminovitz, Silviu Itescu, Mary Donovan, Elizabeth Burke, Julie Webb, Katherine Leitz, Niloo Edwards, Donna Mancini, Columbia University, NY, NY

Zdroj:	In Journal of Heart and Lung Transplantation 1999 18(1):45-45
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu